NEW YORK (GenomeWeb News) – Belgian molecular diagnostics firm Biocartis said today that it has signed a deal under which its Idylla RAS biomarker tests will be made available by Amgen to reference hospitals in Brazil, Canada, Columbia, Mexico, Saudi Arabia, Spain, and Turkey.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.